Market Update by Liontrust – Q3 2024
Q3 2024 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.
Q3 2024 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.
In this article, Stephen Yiu reflects on the Blue Whale Growth Strategy’s impressive performance over the past seven years, navigating a full market cycle and global uncertainties. Looking ahead, the strategy remains focused on identifying high-quality businesses poised for growth, with the aim of delivering consistent outperformance for investors in the future.
Q2 2024 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.
Q1 2024 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.
In this article, Stephen Yiu, discusses how in today’s volatile landscape, Blue Whale Growth Fund maintains a steadfast commitment to its high-conviction approach.
In this article, Stephen Yiu, discusses the performance of the Blue Whale fund over the last 6 years. Yiu also discusses 2023 and beyond.
Final quarter of 2023 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.
Third quarter of 2023 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.
In this article, Stephen Yiu, discusses the performance of the Blue Whale fund over the last 6 years. Yiu also discusses 2023 and beyond.
First quarter of 2023 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.
The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. Sign up and open your account for free, within minutes.
You are leaving medirect.com.mt
Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.
Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.
We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.
For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.